Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago
50 mg
10 x 10
৳8.50

Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.

All price changes →

Save on this medicine

Same active ingredient — pay up to 41% less

These brands contain the same active ingredient (Tiemonium Methylsulfate). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.

From ৳8.50 (10 x 10)
Available as: 50 mg · 10 x 10

Indications & Uses

Spanium is an antispasmodic drug that reduces muscles spasm of the intestine, biliary system, bladder and uterus. It is used in symptomatic treatment of pain related to functional disorders of the digestive tract and biliary system. It is also indicated for the treatment of spasm and pain in urological and gynaecological diseases.

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

Tablet/Syrup- Adult: usual dose is 2-6 tablets or 3-9 teaspoonfuls syrup daily in divided doses. Children: 3 ml/kg or 6 mg/kg body weight daily in divided doses. Injection: 1 injection 3 times daily, through Intravenous route slowly or Intramuscular route.Suppository: 20 mg suppository two or three times daily, through rectal route.

Side Effects

Spanium Methylsulphate may have the risk of hypotension & tachycardia in certain individuals.

Cautions & Contraindications

Warnings & Precautions

Caution should be taken during treatment of patients with disorders of the prostate. Caution should also be taken in case of chronic bronchitis, coronary insufficiency, ambient hyperthermia, renal & hepatic insufficiency. The risks of visual disturbances can make it dangerous to drive or use machines.

Contraindications

It should not be used in urethroprostatic disorder involving a risk of urine retension. It is contraindicated in patient with having risk of angle closure glaucoma.

Last updated: 20 Aug 2026